News Website

Vaginal estrogen therapy not associated with increased risk of endometrial cancer recurrence - Contemporary OB/GYN

Vaginal estrogen therapy not associated with increased risk of endometrial cancer recurrence Contemporary OB/GYN

Published: March 5, 2026, 12:23 a.m.

Read Full Article

Walking daily to raise awareness of ‘terrible’ disease - Fenland Citizen

Walking daily to raise awareness of ‘terrible’ disease Fenland Citizen

Published: March 4, 2026, 12:01 p.m.

Read Full Article

Ananda Pharma Receives MHRA And NHS Ethics Approval For Endocan Phase 2 Clinical Trial For Endometriosis - marketscreener.com

Ananda Pharma Receives MHRA And NHS Ethics Approval For Endocan Phase 2 Clinical Trial For Endometriosis marketscreener.com

Published: March 4, 2026, 11:51 a.m.

Read Full Article

ANANDA PHARMA LTD ("Ananda" or the "Company") : MHRA and NHS Ethics Approval Received for ENDOCAN Phase 2 Clinical Trial for Endometriosis - lelezard.com

ANANDA PHARMA LTD ("Ananda" or the "Company") : MHRA and NHS Ethics Approval Received for ENDOCAN Phase 2 Clinical Trial for Endometriosis lelezard.com

Published: March 4, 2026, 10:17 a.m.

Read Full Article

ANANDA PHARMA LTD ("Ananda" or the "Company") : MHRA and NHS Ethics Approval Received for ENDOCAN Phase 2 Clinical Trial for Endometriosis - Bolsamania

ANANDA PHARMA LTD ("Ananda" or the "Company") : MHRA and NHS Ethics Approval Received for ENDOCAN Phase 2 Clinical Trial for Endometriosis Bolsamania

Published: March 4, 2026, 7:30 a.m.

Read Full Article

Cambridgeshire gym boss takes on daily walk to highlight ‘terrible’ disease - Cambs Times

Cambridgeshire gym boss takes on daily walk to highlight ‘terrible’ disease Cambs Times

Published: March 4, 2026, 7 a.m.

Read Full Article

Cambridgeshire gym boss takes on daily walk to highlight ‘terrible’ disease - Ely Standard

Cambridgeshire gym boss takes on daily walk to highlight ‘terrible’ disease Ely Standard

Published: March 4, 2026, 7 a.m.

Read Full Article

Construction and initial validation of key gene network for progesterone resistance in endometrial cancer based on genome-wide CRISPR screening - Nature

Construction and initial validation of key gene network for progesterone resistance in endometrial cancer based on genome-wide CRISPR screening Nature

Published: March 3, 2026, 10:36 a.m.

Read Full Article

Endometriosis Shuswap looking to spread the word about the disease - Castanet

Endometriosis Shuswap looking to spread the word about the disease Castanet

Published: March 3, 2026, 3 a.m.

Read Full Article

Acrivon Therapeutics Conference Highlights ACR-368 Phase 2B Data, 52% ORR in Serous Endometrial Cancer - Defense World

Acrivon Therapeutics Conference Highlights ACR-368 Phase 2B Data, 52% ORR in Serous Endometrial Cancer Defense World

Published: March 2, 2026, 6:50 p.m.

Read Full Article

Latest Articles

Vaginal estrogen therapy not associated with increased risk of endometrial cancer recurrence - Contemporary OB/GYN

Walking daily to raise awareness of ‘terrible’ disease - Fenland Citizen

Ananda Pharma Receives MHRA And NHS Ethics Approval For Endocan Phase 2 Clinical Trial For Endometriosis - marketscreener.com

ANANDA PHARMA LTD ("Ananda" or the "Company") : MHRA and NHS Ethics Approval Received for ENDOCAN Phase 2 Clinical Trial for Endometriosis - lelezard.com

ANANDA PHARMA LTD ("Ananda" or the "Company") : MHRA and NHS Ethics Approval Received for ENDOCAN Phase 2 Clinical Trial for Endometriosis - Bolsamania

Cambridgeshire gym boss takes on daily walk to highlight ‘terrible’ disease - Cambs Times

Cambridgeshire gym boss takes on daily walk to highlight ‘terrible’ disease - Ely Standard

Construction and initial validation of key gene network for progesterone resistance in endometrial cancer based on genome-wide CRISPR screening - Nature

Endometriosis Shuswap looking to spread the word about the disease - Castanet

Acrivon Therapeutics Conference Highlights ACR-368 Phase 2B Data, 52% ORR in Serous Endometrial Cancer - Defense World

Subscribe to Our Newsletter